These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29549189)

  • 61. No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS.
    Pisa M; Guerrieri S; Di Maggio G; Medaglini S; Moiola L; Martinelli V; Comi G; Leocani L
    Neurology; 2017 Dec; 89(24):2469-2475. PubMed ID: 29142087
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients.
    Hasan KM; Gupta RK; Santos RM; Wolinsky JS; Narayana PA
    J Magn Reson Imaging; 2005 Jun; 21(6):735-43. PubMed ID: 15906348
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
    Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
    Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma neurofilament light chain levels are predictors of disease activity in multiple sclerosis as measured by four-domain NEDA status, including brain volume loss.
    Szilasiová J; Mikula P; Rosenberger J; Fedičová M; Gdovinová Z; Urban P; Frigová L
    Mult Scler; 2021 Nov; 27(13):2023-2030. PubMed ID: 33635154
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Harmonizing DTI measurements across scanners to examine the development of white matter microstructure in 803 adolescents of the NCANDA study.
    Pohl KM; Sullivan EV; Rohlfing T; Chu W; Kwon D; Nichols BN; Zhang Y; Brown SA; Tapert SF; Cummins K; Thompson WK; Brumback T; Colrain IM; Baker FC; Prouty D; De Bellis MD; Voyvodic JT; Clark DB; Schirda C; Nagel BJ; Pfefferbaum A
    Neuroimage; 2016 Apr; 130():194-213. PubMed ID: 26872408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution of Cortical Diffusion Tensor Imaging Changes in Multiple Sclerosis.
    Stock B; Shrestha M; Seiler A; Foerch C; Hattingen E; Steinmetz H; Deichmann R; Wagner M; Gracien RM
    Front Physiol; 2020; 11():116. PubMed ID: 32231581
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of white matter in patients with multiple sclerosis through diffusion tensor magnetic resonance imaging.
    Andrade RE; Gasparetto EL; Cruz LC; Ferreira FB; Domingues RC; Marchiori E; Domingues RC
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):561-4. PubMed ID: 17876390
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.
    Río J; Rovira À; Tintoré M; Otero-Romero S; Comabella M; Vidal-Jordana Á; Galán I; Castilló J; Arrambide G; Nos C; Tur C; Pujal B; Auger C; Sastre-Garriga J; Montalban X
    Mult Scler; 2018 Mar; 24(3):322-330. PubMed ID: 28287331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
    Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions.
    Braley TJ; Lee YH; Mohan S; Segal BM; Berini S; Srinivasan A
    J Comput Assist Tomogr; 2012; 36(4):410-5. PubMed ID: 22805669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple Sclerosis Fatigue: A Longitudinal Structural MRI and Diffusion Tensor Imaging Study.
    Yarraguntla K; Seraji-Bozorgzad N; Lichtman-Mikol S; Razmjou S; Bao F; Sriwastava S; Santiago-Martinez C; Khan O; Bernitsas E
    J Neuroimaging; 2018 Nov; 28(6):650-655. PubMed ID: 30039613
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
    Bozzali M; Spanò B; Parker GJ; Giulietti G; Castelli M; Basile B; Rossi S; Serra L; Magnani G; Nocentini U; Caltagirone C; Centonze D; Cercignani M
    Mult Scler; 2013 Aug; 19(9):1161-8. PubMed ID: 23325589
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Brain macro- and microscopic damage in patients with paediatric MS.
    Absinta M; Rocca MA; Moiola L; Ghezzi A; Milani N; Veggiotti P; Comi G; Filippi M
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1357-62. PubMed ID: 20660915
    [TBL] [Abstract][Full Text] [Related]  

  • 76. VEP Score of a Left Eye Had Predictive Values for Achieving NEDA-3 over Ten Years in Patients with Multiple Sclerosis.
    Miletic-Drakulic S; Miloradovic I; Jankovic V; Azanjac-Arsic A; Lazarevic S
    Sensors (Basel); 2022 Nov; 22(22):. PubMed ID: 36433445
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
    Sormani MP; Muraro PA; Saccardi R; Mancardi G
    Mult Scler; 2017 Feb; 23(2):201-204. PubMed ID: 27207454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus.
    Kozora E; Filley CM; Erkan D; Uluğ AM; Vo A; Ramon G; Burleson A; Zimmerman RD; Lockshin MD
    Lupus; 2018 Oct; 27(11):1810-1818. PubMed ID: 30103647
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.
    Prosperini L; Lucchini M; Haggiag S; Bellantonio P; Bianco A; Buscarinu MC; Buttari F; Centonze D; Cortese A; De Giglio L; Fantozzi R; Ferraro E; Fornasiero A; Francia A; Galgani S; Gasperini C; Marfia GA; Millefiorini E; Nociti V; Pontecorvo S; Pozzilli C; Ruggieri S; Salvetti M; Sgarlata E; Mirabella M
    Neurology; 2018 Jul; 91(2):e153-e161. PubMed ID: 29875218
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identifying the start of multiple sclerosis injury: a serial DTI study.
    Ontaneda D; Sakaie K; Lin J; Wang X; Lowe MJ; Phillips MD; Fox RJ
    J Neuroimaging; 2014; 24(6):569-576. PubMed ID: 25370339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.